A Phase 1/2a study of CNP520 for Alzheimer's Disease.
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Umibecestat (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- 01 Oct 2016 New trial record
Latest Information Update: 01 Oct 2016